210.50p-0.50 (-0.24%)27 Feb 2024, 17:56
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Puretech Health PLC Fundamentals

Company NamePuretech Health PLCLast Updated2024-02-27
Shares in Issue269.950 mMarket Cap£568.24 m
PE Ratio227.27Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-$0.18EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0369Debt Equity Ratio0.0389
Asset Equity Ratio1.3629Cash Equity Ratio0.6920
Quick Ratio7.1905Current Ratio7.31
Price To Book Value1.4051ROCE0

Puretech Health PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Puretech Health PLC Company Financials

Tangible Assets$37.24 m$43.94 m
Intangible Assets$831,000.00$987,000.00
Investments$261.04 m$397.18 m
Total Fixed Assets$316.45 m$444.20 m
Debtors$11.87 m$18.29 m
Cash & Equivalents$350.10 m$465.71 m
Other Assets$17.35 m$2.10 m
Total Assets$702.65 m$946.01 m
Creditors within 1 year$96.89 m$226.13 m
Creditors after 1 year$58.17 m$135.72 m
Other Liabilities00
Total Liabilities$155.06 m$361.86 m
Net assets$547.59 m$584.15 m
Called up share capital$5.46 m$5.44 m
Share Premium$289.62 m$289.30 m
Profit / Loss-$92.78 m-$58.95 m
Other Equity$542.22 m$593.51 m
Preference & Minorities$5.37 m-$9.37 m
Total Capital Employed$547.59 m$584.15 m
Debt Ratio$0.06$0.07
Assets / Equity1.36291.3629
Cash / Equity0.69200.6920
Cash Flow20222021
Cash from operating activities-$178.79 m-$158.27 m
Cashflow before financing-$208.62 m-$135.55 m
Increase in Cash-$315.84 m$61.83 m
Turnover$2.09 m$9.98 m
Cost of sales00
Gross Profit00
Operating Profit-$197.81 m-$150.28 m
Pre-Tax profit-$92.78 m-$58.95 m

Puretech Health PLC Company Background

ActivitiesPureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Latest Interim Date29 Aug 2023
Latest Fiscal Year End Date28 Apr 2023

Puretech Health PLC Directors

2020-08-27Dr. Bennett M. ShapiroNon-Executive Director
2023-07-27Dr. Bharatt M. ChowriraExecutive Director
2023-07-27Dr. John L. LaMattinaIndependent Director
2023-07-27Dr. Robert S. LangerDirector
2023-07-27Dr. Raju S. KucherlapatiInterim Chairman of the Board and Senior Independent Director
2019-09-09Mr. Joichi ItoNon-Executive Director,Chairman
2022-12-28Dame Marjorie Morris ScardinoNon-Executive Director,Senior Independent Director
2023-04-28Mr. Christopher ViehbacherChairman of the Board
2023-07-27Ms. Kiran Mazumdar-ShawNon-Executive Director
2023-07-27Ms. Daphna ZoharExecutive Director,Chief Executive Officer
2021-01-29Mr. Stephen MunizExecutive Director,Chief Operating Officer and Company Secretary
2023-07-27Ms. Sharon Barber-LuiIndependent Director

Puretech Health PLC Contact Details

Company NamePureTech Health PLC
Address6 St Andrew Street, 5th Floor, London, EC4A 3AE

Puretech Health PLC Advisors

StockbrokerPeel Hunt LLP
Phone+44 2074188900
StockbrokerJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
StockbrokerNumis Securities Limited
Phone+44 2072601000
Remuneration ConsultantNew Bridge Street
Phone+44 2070869341
Fax+44 2070869341
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Phone+44 2073111000
Fax+44 2073113311
SolicitorDLA Piper LLP
Phone+44 8700111111
Fax+44 2077966666
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101